Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2014161004) COMPOSITIONS AND METHODS FOR THE DELIVERY OF DRUGS TO THE OCULAR SURFACE BY CONTACT LENSES
Latest bibliographic data on file with the International Bureau   
Pub. No.: WO/2014/161004 International Application No.: PCT/US2014/032412
Publication Date: 02.10.2014 International Filing Date: 31.03.2014
IPC:
C07K 14/78 (2006.01) ,A61K 47/48 (2006.01) ,A61P 27/02 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
78
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27
Drugs for disorders of the senses
02
Ophthalmic agents
Applicants:
MACKAY, John, Andrew [US/US]; US
WANG, Wan [CN/US]; US
LAURIE, Gordon, W. [US/US]; US
Inventors:
MACKAY, John, Andrew; US
WANG, Wan; US
LAURIE, Gordon, W.; US
Priority Data:
61/806,55829.03.2013US
Title (EN) COMPOSITIONS AND METHODS FOR THE DELIVERY OF DRUGS TO THE OCULAR SURFACE BY CONTACT LENSES
(FR) COMPOSITIONS ET PROCÉDÉS POUR L'ADMINISTRATION DE MÉDICAMENTS À LA SURFACE OCULAIRE PAR DES LENTILLES DE CONTACT
Abstract:
(EN) Disclosed herein are novel methods and compositions for targeting ocular diseases. One aspect relates to a contact lens comprising an elastin-like peptide (ELP) component and optionally a therapeutic agent. Also provided are methods for treating ocular diseases comprising administering a contact lens of the disclosure to a subject in need thereof
(FR) L'invention concerne de nouveaux procédés et de nouvelles compositions pour cibler des maladies oculaires. Un aspect concerne une lentille de contact comprenant un composant de peptide de type élastine (ELP) et facultativement un agent thérapeutique. L'invention concerne également des procédés de traitement de maladies oculaires comprenant l'administration d'une lentille de contact de l'invention à un sujet en ayant besoin.
 front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)